Skip to main content
eScholarship
Open Access Publications from the University of California

Pyrazinamide resistance, Mycobacterium tuberculosis lineage and treatment outcomes in San Francisco, California

  • Author(s): Nahid, Payam
  • Hopewell, Philip
  • Budzik, JM
  • Jarlsberg, LG
  • Higashi, J
  • Grinsdale, J
  • Hopewell, PC
  • Kato-Maeda, M
  • et al.

Published Web Location

http://europepmc.org/articles/PMC3997554?pdf=render
No data is associated with this publication.
Abstract

Background: Pyrazinamide (PZA) is a first line agent for the treatment of active tuberculosis. PZA is also considered a potent companion drug for newer regimens under development. There are limited data on the demographic, clinical, and pathogen characteri

Many UC-authored scholarly publications are freely available on this site because of the UC Academic Senate's Open Access Policy. Let us know how this access is important for you.

Item not freely available? Link broken?
Report a problem accessing this item